Optimisation of DNA vaccines for the prophylaxis and modulation of herpes simplex virus infections

Bibliography

• LIESEGANG TJ, MELTON LJ, DALY PJ, ILSTRUP DM:Epidermiology of ocular herpes simplex virus: Incidence in Rochester, Minn, 1950 through 1982.. Arch. Opthalmol. (1989) 107:1155–1159.
   PubMed Web of Science ®Google Scholar
• Committee on issues and priorities for new vaccine develop-ment. Appendix I: prospects for immunizing against herpes simplex viruses 1 and 2. In: New Vaccine Develop-ment: Establishing Priorities. National Academy Press, Washington DC, USA (1985): 1105–1111.
   Google Scholar
• BERNSTEIN DI, STANBERRY LR: Herpes simplex virus vaccines. Vaccine (1999) 17:1681–1689.
   PubMed Web of Science ®Google Scholar
• COX GJM, ZAMB TJ, BABIUK LA: Bovine herpes virus I: Immune responses in mice and cattle injected with plasmid DNA. J. Virol. (1993) 67:5664–5667.
   PubMed Web of Science ®Google Scholar
• KRIESEL JD, SPRUANCE SL, DAYNES RA, ARANEO BA:Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus Type 2 disease. J. Infect. Dis. (1996) 173:536–541.
   PubMed Web of Science ®Google Scholar
• MANICKAN E, ROUSE RJD, YU Z, WIRE WS, ROUSE BT:Genetic immunization against herpes simplex virus: Protection is mediated by CD4+ T-lymphocytes. J. Immunol. (1995) 155:259–265.
   PubMed Web of Science ®Google Scholar
• BOURNE N, STANBERRY LR, BERNSTEIN DI, LEWD: DNAimmunization against experimental genital herpes simplex virus infection. J. Infect. Dis. (1996) 173:800–807.
   PubMed Web of Science ®Google Scholar
• MANICKAN E, YU Z, ROUSE RJD, WIRE WS, ROUSE BT:Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP27. Viral Immunol. (1995) 8:53–61.
   PubMed Web of Science ®Google Scholar
• MANICKAN E, FRANCOTTE M, KUKLIN NA, DEWERCHINM, MOLITOR C, GHEYSEN D et al.: Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Thl T-cells. J. Virol. (1995) 69:4711–4716.
   PubMed Web of Science ®Google Scholar
• BERNSTEIN DI, TEPE ER, MESTER JC, ARNOLD RL, STANBERRY LR, HIGGINS TJ: Effects of DNA immuniza-tion formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus. Vaccine (1999) 17:1964–1969.
   PubMed Web of Science ®Google Scholar
• MESTER JC, TWOMEY TA, TEPE ET, BERNSTEIN DI: Immunity induced by DNA immunization with herpes simplex virus Type 2 gjycoproteins B and C. Vaccine (1999) 18:875–883.
   PubMed Web of Science ®Google Scholar
• MCCLEMENTS WL, ARMSTRONG ME, KEYS RD, LIU MA:Immunization with DNA vaccine encoding glycopro-tein D or gjycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA (1996) 93:11414–11420.
   PubMed Web of Science ®Google Scholar
• SUTER M, LEW AM, GROB P, ADEMA GJ, ACKERMANN M,SHORTMAN K, FRAEFEL C: BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc. Natl. Acad. Sci. USA (1999) 96:12697–12702.
   PubMed Web of Science ®Google Scholar
• PACHUK CJ, ARNOLD R, HEROLD K, CICCARELLI RB, HIGGINS TJ: Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice. Curr. Top. Micro biol. Immunol. (1998) 226:79–89.
   PubMed Web of Science ®Google Scholar
• GOULD-FOGERITE S, MANNINO RJ: Mucos al and systemic immunization using cochleate and liposome vaccines. J. Liposome Res. (1996) 2:357–379.
   Google Scholar
• MANNINO RJ, CANKI M, FEKETEOVA E, SCOLPINO AJ, WANG Z, ZHANG F et al.: Targeting immune response induction with cochleate and liposome-based vaccines. Adv. Drug Deliv. Rev. (1998) 32:273–287.
   PubMed Web of Science ®Google Scholar
• ZARIF L, MANNINO RJ: Cochleates. Lipid-based vehicles for gene delivery-concept, achievements and future development. Adv. Exp. Med. Biol. (2000) 465:83–93.
   Google Scholar
• KADOWAKI S-E, CHEN Z, ASANUMA H, AIZWA C, KURATA T, TAMURA SI: Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electropora-lion. Vaccine (2000) 18:2779–2788.
   PubMed Web of Science ®Google Scholar
• WIDERA G, AUSTIN M, RABUSSAY D, GOLDBECK C, BARNETT SW, CHEN M et al.: Increased DNA vaccine delivery and irnmunogenicity by electroporation in vivo. J. Immunol. (2000) 164:4635–4640.
   PubMed Web of Science ®Google Scholar
• CONDON C, WATKINS SC, CELLUZZI CM, THOMPSON K,FALO LD: DNA based immunization by in vivo transfec-tion of dendritic cells. Nature Med. (1996) 2:1122–1128.
   PubMed Web of Science ®Google Scholar
• DOE B, SELBY M, BARNETT S, BAENZIGER J, WALKER CM:Induction of cytotoxic T-lymphocytes by intramus-cular immunization with plasmid DNA is facilitated by bone marrow derived cells. Proc. Natl. Acad. Sci. USA (1996) 93:8578–8583.
   PubMed Web of Science ®Google Scholar
• ZAROZINSKI CC, FYNAN EF, SELIN LK, ROBINSON HL, WELSH RM: Protective CTL-dependent immunity and enhanced irnmunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. (1995) 154:4010–4017.
   PubMed Web of Science ®Google Scholar
• CODON C, WATKINS SC, CELLUZZI CM, THOMPSON K,FALO LD Jr: DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. (1996) 2:1122–1128.
   PubMed Web of Science ®Google Scholar
• ROUSE RJD, NAIR SK, LYDY SL, BOWEN JC, ROUSE BT:Induction of in vitro primary cytotoxic T-lymphocytes responses with DNA encoding herpes simplex virus proteins. J. Vriol. (1994) 68:5685–5689.
   PubMed Web of Science ®Google Scholar
• MANICKAN E, KANANGAT S, ROUSE RJ, YU Z, ROUSE BT: Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukoc. Biol. (1997) 61:125–132.
   PubMed Web of Science ®Google Scholar
• AGGARWAL A, KUMAR S, RICHARD J, HONE D, GROSS M, SADOFF J: Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med. (1990) 172:1083–1090.
   PubMed Web of Science ®Google Scholar
• CATIC A, DIETRICH G, GENTSCHEV I, GOEBEL W, KAUFMANN SH, HESS J: Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages. Microbes Infect. (1999) 1:113–121.
   PubMed Web of Science ®Google Scholar
• DARJI A, GUZMAN CA, GERSTEL B, WACHHOLZ P, TIMMISKN, WEHLAND J et al.: Oral somatic transgene vaccination using attenuated S. typhimurium. Cell (1997) 91:765–775.
   Web of Science ®Google Scholar
• DUBENSKY TW, DRIVER DA, POLO JM, BELLI BA, LATHAM EM, IBANEZ CE et al.: Sindbis virus DNA-based expression vectors: Utility for in vitro and in vivo gene transfer. J. Virol. (1996) 70:508–519.
   PubMed Web of Science ®Google Scholar
• HARIHARAN MJ, DRIVER DA, TOWNSEND K, BRUMM D, POLO JM, BELLI BA et al.: DNA immunization against herpes simplex virus: Enhanced efficacy using a sindbis virus-based vector. J. Virol. (1998) 72:950–958.
   PubMed Web of Science ®Google Scholar
• MESTER J, MILLIGAN GN, BERSTEIN DI: The irnmuno-biology of herpes simplex virus, In: Genital and neonatal herpes. Stanberry LR (Ed.), John Wiley and Sons. Ltd. (1996): 49–91.
   Google Scholar
• KUKLIN NA, DAHESHIA M, KAREM K, MANICKAN E, ROUSE BT: Induction of mucosal immunity against herpes simplex virus by DNA immunization. J. Virol. (1997) 71:3138–3145.
   PubMed Web of Science ®Google Scholar
• KAREM K, BOWEN J, KUKLIN N, ROUSE BT: Protective immunity against herpes simplex virus (HSV) Type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. J. Gen. Virol. (1997) 78:427–434.
   PubMed Web of Science ®Google Scholar
• YU Z, KAREM KL, KANANGAT S, MANICKAN E, ROUSE BT: Protection by minigenes: a novel approach of DNA vaccines. Vaccine (1998) 16:1660–1667.
   PubMed Web of Science ®Google Scholar
• XIANG Z, ERTL HC: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmid expressing cytokines. Immunity (1995) 2:129–135.
   PubMed Web of Science ®Google Scholar
• AHLERS JD, DUNLOP N, ALLING DW, NARA PL, BERZOFSKY JA: Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine cinstructs: granulocyte-macrophage colony-stimulating factor and TNF-a synergize with IL-12 to ehance induction of cytotoxic T lymphocytes. J. Immunol. (1997) 158:3947–3958.
   PubMed Web of Science ®Google Scholar
• BELYAKOV IM, AHLERS JD, CLEMENTS JD, STROBER W,BERZOFSKY JA: Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL. J. Immunol. (2000) 165:6454–6462.
   PubMed Web of Science ®Google Scholar
• OKADA E, SASAKI S, ISHII N, AOKI I, YASUDA T,NISHIOKA K et al.: Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expres sing plasmids in liposome induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. (1997) 159:3638–3647.
   Google Scholar
• XIN KQ, HAMAJIMA K, SASAKI S, TSUJI T, WATABE S, OKADA E et al.: IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine. Vaccine (1999) 17:858–866.
   PubMed Web of Science ®Google Scholar
• SIN JI, KIM JI, UGEN KE, CICCARELLI RB, HIGGINS TJ, WEINER DB Enhancement of protective humoral (Th2) and cell-mediated (Thl) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur. J. Immunol. (1998) 28:3530–3540.
   PubMed Web of Science ®Google Scholar
• SIN JI, KIM JI, BOYER JD, CICCARELLI RB, HIGGINS TJ, WEINER DB: In vivo modulation of vaccine-induced immune responses toward a Thl phenotype increase potency and vaccine effectiveness in a herpes simplex virus Type 2 mouse model. J. Virol. (1999) 73:501–509.
   PubMed Web of Science ®Google Scholar
• SIN JI, KIM JI, ARNOLD RL, SHROFF KE, McCALLUS D, PACHUK C et al.: IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: 11-12 enhances Thl-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. (1999) 162:2912–2921.
   PubMed Web of Science ®Google Scholar
• CHUN S, DAHESHIA M, KUKLIN NA, ROUSE BT: Modula-tion of viral irnmunoinflanamatory responses with cytokine DNA-administered by different routes. J. Virol. (1998) 72:5545–5551.
   PubMed Web of Science ®Google Scholar
• KUKLIN NA, DAHESHIA M, CHUN S, ROUSE BT: Immuno-modulation by mucosal gene transfer using TGF-I3 DNA. J. Clin. Invest. (1998) 102:438–444.
   PubMed Web of Science ®Google Scholar
• DAHESHIA M, KUKLIN N, KANANGAT S, MANICKAN E, ROUSE BT: Suppression of ongoing ocular inflamma-tory disease by topical administration of plasmid DNA encoding IL-10. J. Immunol. (1997) 159:1945–1952.
   PubMed Web of Science ®Google Scholar
• IWASAKI A, STIERNHOLM BJ, CHAN AK, BERNSTEIN NL, BARBER BH: Enhanced CTL responses mediated by plasmid DNA irnmunogens encoding co-stimulatory molecules and cytokines. J. Immunol. (1997) 158:4591–4601.
   PubMed Web of Science ®Google Scholar
• PASQUINI S, XIANG Z, WANG Y, HE Z, DENG H, BLASZCZYK-THURIN M et al.: Cytokines and co-stimulatory molecules as genetic adjuvants. Immunol. Cell Biol. (1997) 75:397–401.
   PubMed Web of Science ®Google Scholar
• TSUJI T, HAMAJIMA K, ISHI N, AOKI I, FUKUSHIMA J, XINKQ et al.: Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur. J. Immunol. (1997) 27:782–787.
   PubMed Web of Science ®Google Scholar
• SIN JI, KIM J, DANG K, LEE D, PATCHUK C, SATISH-CHANDRAN C, WEINER DB: LFA-1 plasmid DNA enhances Ag-specific humoral- and cellular mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection. Cell Immunol. (2000) 203:19–28.
   PubMed Web of Science ®Google Scholar
• MENDOZA RB, CANTWELL MJ, KIPPS TJ: Immunostimu-latory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J. Immunol. (1997) 159:5777–5781.
   PubMed Web of Science ®Google Scholar
• BOYER JD, KIM J, UGEN K, COHEN AD, AHN L, SCHUMANN K et al.: HIV-1 DNA vaccines and chemokines. Vaccine (1999) 2:S53–S64.
   Google Scholar
• SIN JI, KIM JJ, PACHUK C, SATISHCHANDRAN C, WEINERDB: DNA vaccines encoding interleukin-8 and RANfES enhance antigen-specific Thl-type CD4+ T cell-mediated protective immunity against herpes simplex virus Type 2 in vivo. J. Virol (2000) 74:M73–11180.
   Web of Science ®Google Scholar
• LU Y, XIN KQ, HAMAJIMA K, TSUI T, AOKI I, YANG J et al.:Macrophage inflammatory protein-lalpha (1111P-1a) expression plasmid enhances DNA vaccine-induced immune response against HIV-1. Clin. Exp. Immunol. (1999) 115:335–341.
   PubMed Web of Science ®Google Scholar
• EO SK, LEE S, CHUN S, ROUSE BT: Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. J. Virol. (2001) In press.
   Google Scholar
• EO SK, LEE S, KUMARAGURU U, ROUSE BT: Immunopo-tentiating of DNA vaccine against herpes simplex virus via co-delivery of palsmid DNA expressing CCR7 ligands. (Submitted).
   Google Scholar
• RODRIGUEZ F, ZHANG J, WHITTON JL: DNA immuniza-tion: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. (1997) 71:8497–8503.
   PubMed Web of Science ®Google Scholar
• KILNMAN DM, YAMSHCHIKOV G, ISHIGATSUBO Y: Contribution of CpG motifs to the irnmunogenicity of DNA vaccines. J. Immunol. (1997) 158:3635–3639.
   PubMed Web of Science ®Google Scholar
• LIU DW, TSAO YP, KUNG JT, DING YA, SYTWU HK, MAO X et al.: Recombinant adeno-associated virus expressing human papillomavirus Type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer./ Virol. (2000) 74:2888–2894.
   PubMed Web of Science ®Google Scholar
• FLO J, TISMINETZKY S, BARALLE F: Modulation of the immune response to DNA vaccine by co-delivery of co-stimulatory molecules. Immunology (2000) 100:259–269.
   PubMed Web of Science ®Google Scholar
• MANICKAN E, KAREM KL, ROUSE BT: DNA vaccines-Amodern gimmick or a boon to vaccinology? Crit. Rev. Immunol. (1997) 17:139–154.
   Google Scholar
• KRIEG AM, YI AK, MATSON S et al.: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 374:546–549.
   PubMed Web of Science ®Google Scholar
• STACEY KJ, SWEET MJ, HUME DA: Macrophage ingestand are activated by bacterial DNA. J. Immunol. (1996) 157:2116–2122.
   PubMed Web of Science ®Google Scholar
• JAKOB T, WALKER PS, KRIEG AM, UDEY MC, VOGEL JC: Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Thl responses by immunostimulatory DNA. J. Immunol. (1998) 161:3042–3049.
   PubMed Web of Science ®Google Scholar
• COWDERY JS, CHACE JH, YI AK, KRIEG AM: Bacterial DNA induces NK cells to produce 1FN-_ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. (1996) 156:4570–4575.
   PubMed Web of Science ®Google Scholar
• BENDIGS S, SALZER U, LIPFORD GB, WAGNER H, HEEG K:CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur.J. Immunol. (1999) 29:1209–1218.
   PubMed Web of Science ®Google Scholar
• GALLICHAN WS, WOOLSTENCROFT RN, GAURASCI T, McCLUSKIE MJ, DAVIS HL, ROSENTHAL KL Mucosal immunization with CpG ODN induces sigificant IgA and protection against HSV-2 in the genital tract. Proceedings of the 256 International Herpesvirus Workshop (2000) 5–59.
   Google Scholar
• CHU RS, TARGONI OS, KRIEG AM, LEHMANN PV, HARDING CV: CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Thl) immunity. J. Exp. Med. (1997) 186:1623–1631.
   PubMed Web of Science ®Google Scholar
• KRIEG AM, WU T, WEERATNA R, EFLER SM, LOVE-HOMAN L, YANG L et al.: Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA (1998) 95:12631–12636.
   PubMed Web of Science ®Google Scholar
• RAMSAY AJ, LEONG KH, RAMSHAW IA: DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol. Cell Biol. (1997) 75:382–388.
   PubMed Web of Science ®Google Scholar
• RAMSHAW IA, RAMSAY AJ: The prime-boost strategy: exciting prospects for improves vaccination. Immunol. Today (2000) 21:163–165.
   PubMedGoogle Scholar
• SIN JI, BAGARAZZI M, PACHUK C, WEINER DB: DNA-priming-protein boosting enhances both antigen-specific antibody and Thl-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model. DNA Cell Biol. (1999) 18:771–779.
   PubMed Web of Science ®Google Scholar
• LEES, CHUN S, EO SK, ROUSE BT: Immunization via the gastric mucosa - an approach to boost and modulate immunity with DNA vaccine. Crtl. Eur. J. Immunol. (2000) 25.
   Google Scholar
• CHUN S, DAHESHIA M, LEES, EO SK, ROUSE BT: Distribu-tion fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10. J. Immunol. (1999) 163:2393–2402.
   PubMed Web of Science ®Google Scholar
• CASARES S, INABA K, BRUMEANU TD, STEIMAN IM, BONA CA: Antigen presentation by dendritic cells after immunization with DNA encoding a major histocom-patibility complex class II-restricted viral epitope. J. Exp. Med. (1997) 186:1481–1486.
   PubMed Web of Science ®Google Scholar
• BOULOC A, WALKER P, GRIVEL JC, VOGEL JC, KATZ SI: Immunization through dermal delivery of protein-encoding DNA: a role for migratory dendritic cells. Eur. J. Immunol. (1999) 29:446–454.
   PubMed Web of Science ®Google Scholar
• DOE B, SELBY M, BARNETT S, BAENZIGER J, WALKER CM:Induction of cytotoxic T lymphocytes by intramus-cular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA (1996) 93:8578–8583.
   PubMed Web of Science ®Google Scholar
• WITMER-PACK MD, CROWLEY MT, INABA K, STEINMANRM: Macrophage, but not dendritic cells, accumulate colloidal carbon following administration in situ. J. Cell Sci. (1993) 105:965–973.
   PubMedGoogle Scholar
• BEVAN MJ: Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. (1995) 182:639–641.
   PubMed Web of Science ®Google Scholar
• FU TM, ULMER JB, CAULFIELD MJ, DECK RR, FRIEDMAN A,WANG S et al.: Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen-presenting cells and evidence for antigen transfer from myocytes. Mol. Med. (1997) 3:362–371.
   Google Scholar
• CORR M, VON-DAMM A, LEE DJ, TIGHE H: In vivo priming by DNA injection occurs predominantly by antigen transfer. J. Immunol. (1999) 163:4721–4727.
   PubMed Web of Science ®Google Scholar
• PORGADOR A, IRVINE KR, IWASAKI A, BARBER BH, RESTIFO NP, GERMAIN RN: Predominant role for directly transfected dendritic cells in antigen presen-tation to CD8+ T cells after gene gun immunization. J. Exp. Med. 188:1075-1083.
   Google Scholar
• KUMARAGURU U, ROUSE RJ, NAIR SK, BRUCE BD, ROUSEBT: Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immuniza-tion. J. Immunol. (2000) 165:750–759.
   PubMed Web of Science ®Google Scholar